Comparative study of ablative efficacy of intravesical chemotherapy using gemcitabine and mitomycin C with mitomycin C alone for non-muscle invasive bladder carcinoma

Trial Profile

Comparative study of ablative efficacy of intravesical chemotherapy using gemcitabine and mitomycin C with mitomycin C alone for non-muscle invasive bladder carcinoma

Completed
Phase of Trial: Phase II

Latest Information Update: 13 Jul 2015

At a glance

  • Drugs Gentamicin (Primary) ; Mitomycin
  • Indications Bladder cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 13 Jul 2015 New trial record
    • 02 Jun 2015 Patients were enrolled between Feb 2009 and January 2011, according to ASCO 2015 abstract.
    • 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology (ASCO 2015).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top